tagrisso
astrazeneca ab - osimertinib mesilate - karcinom, ne-malih stanica pluća - drugi antitumorski lijekovi, inhibitori протеинкиназы - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
tafinlar
novartis europharm limited - dabrafenib mesilate - melanoma - antineoplastična sredstva - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 i 5. adjuvantne terapije melanomadabrafenib u kombinaciji s trametinib indiciran za адъювантного liječenje odraslih bolesnika s iii fazi melanoma s Браф mutacija v600 daleko, nakon kompletne resekcije. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.
roclanda
santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - ophthalmologicals - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostatske neoplazme - endokrinska terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
alsitek
ab science - masitinib mesilate - amiotrofna lateralna skleroza - antineoplastična sredstva - liječenje bočnog амиотрофического skleroze.
masipro
ab science - masitinib mesilate - mastocitoza - antineoplastična sredstva - liječenje мастоцитоза.
masivet
ab science s.a. - masitinib mesilate - antineoplastična sredstva - psi - liječenje ne-resektabilnih pasa mast-stanica tumora (stupanj 2 ili 3) s potvrđenim mutiranim c-kit tirozin-kinaznim receptorom.
noradrenalin ligula pharma 0,5 mg/ml koncentrat za otopinu za infuziju
ligula pharma d.o.o., iblerov trg 7, zagreb, hrvatska - noradrenalintartarat (norepinefrintartarat) - koncentrat za otopinu za infuziju - 0,5 mg/ml - urbroj: 1 ml koncentrata za otopinu za infuziju sadrži 0,5 mg noradrenalina (norepinefrina) što odgovara 1 mg noradrenalintartarata
razagilin teva 1 mg tablete
teva b.v., swensweg 5, haarlem, nizozemska - razagilinmesilat - tableta - 1 mg - urbroj: svaka tableta sadrži 1 mg razagilina u obliku razagilinmesilata